ALNYLAM PHARMACEUTICALS, INC.: capex
| Value | {"amount": 46902000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2023-01-01 – 2023-09-30 |
| Status | current |
| Entity | ALNYLAM PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:51:53.022865+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/27ffb9c4-ad20-422b-b68e-25c940b07870
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001178670-23-000023Retrieved: 2026-08-19T11:51:53.022865+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001178670/capex/2023-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/27ffb9c4-ad20-422b-b68e-25c940b07870
History
- no predecessors — first report